Indications and uses
For the temporary relief of minor aches & pains of muscles & joints associated with simple backache strains bruises sprains
Stressa™ Back & Neck Pain Relieving Cream
- Manufacturer
- Stressa Incorporated
- Effective date
- 2012-12-05
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:33:55
Label at a glance#
ProductStressa Back and Neck Pain Relieving
Active ingredientMenthol
Label structure8 sections
Dosage and administration
Adults and children 2 years of age and older : Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: Consult a doctor.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient
Menthol 1.25%
Purpose
topical analgesic
Uses
For the temporary relief of minor aches & pains of muscles & joints associated with
- simple backache
- strains
- bruises
- sprains
Warnings
For external use only.
OTC - DO NOT USE SECTION
Do not apply to wounds or damaged skin
OTC - WHEN USING SECTION
When using this product
- avoid contact with eyes
- do not bandage tightly
OTC - STOP USE SECTION
Stop use and ask a doctor if
- conditions worsen or symptoms persist for more than 7 days
- symptoms clear up and occur again within a few days
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.
Children under 2 years of age: Consult a doctor.
Inactive Ingredients
arabica coffee oil, basil oil, cananga oil, carbomer homopolymer type C (allyl pentaerythritol crosslinked), cetostearyl alcohol, coconut oil, dimethicone, galbanum oil, glycerin, glyceryl monostearate, hyssop oil, lemon oil, methyl salicylate, nutmeg oil, palm oil, peppermint oil, phenoxyethanol, picea mariana leaf oil, pine needle oil (pinus sylvestris) polyoxyl 20 cetostearyl ether, rosemary oil, sage oil, shea butter, sodium citrate, sunflower seed oil, tocopherol, water, white wax
PRINCIPAL DISPLAY PANEL - 43g Jar Carton
Stressa™
back & neck
pain relieving cream
for soothing relief
of tense and sore
muscles
net wt. 1.5oz (43g)
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53882-001-02 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d6be-cd31-e053-dbdaa90ab51a | Stressa™ Back & Neck Pain Relieving Cream |
| 53882-001-04 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d6be-cd31-e053-dbdaa90ab51a | Stressa™ Back & Neck Pain Relieving Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53882-001-01 | Stressa Back and Neck Pain Relieving | 43 g in 1 JAR | CREAM | 43 | 1 | |
| 53882-001-02 | Stressa Back and Neck Pain Relieving | 1 in 1 BOX | CREAM | 1 | 1 | |
| 53882-001-03 | Stressa Back and Neck Pain Relieving | 85 g in 1 JAR | CREAM | 85 | 1 | |
| 53882-001-04 | Stressa Back and Neck Pain Relieving | 1 in 1 BOX | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Menthol | ACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| Menthol | ACTIVE MOIETY | L7T10EIP3A | 1 | |
| ARABICA COFFEE OIL | INACTIVE INGREDIENT | IK55HKE887 | 1 | |
| Basil oil | INACTIVE INGREDIENT | Z129UMU8LE | 1 | |
| CANANGA OIL | INACTIVE INGREDIENT | 8YOY78GNNX | 1 | |
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | INACTIVE INGREDIENT | 4Q93RCW27E | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| coconut oil | INACTIVE INGREDIENT | Q9L0O73W7L | 1 | |
| dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Galbanum oil | INACTIVE INGREDIENT | 211UF7M8N1 | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| Hyssop oil | INACTIVE INGREDIENT | 173D71924B | 1 | |
| lemon oil | INACTIVE INGREDIENT | I9GRO824LL | 1 | |
| METHYL SALICYLATE | INACTIVE INGREDIENT | LAV5U5022Y | 1 | |
| Nutmeg oil | INACTIVE INGREDIENT | Z1CLM48948 | 1 | |
| palm oil | INACTIVE INGREDIENT | 5QUO05548Z | 1 | |
| Peppermint oil | INACTIVE INGREDIENT | AV092KU4JH | 1 | |
| phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PICEA MARIANA LEAF OIL | INACTIVE INGREDIENT | Q1J49L1A5O | 1 | |
| PINE NEEDLE OIL (PINUS SYLVESTRIS) | INACTIVE INGREDIENT | 5EXL5H740Y | 1 | |
| POLYOXYL 20 CETOSTEARYL ETHER | INACTIVE INGREDIENT | YRC528SWUY | 1 | |
| Rosemary oil | INACTIVE INGREDIENT | 8LGU7VM393 | 1 | |
| Sage oil | INACTIVE INGREDIENT | U27K0H1H2O | 1 | |
| shea butter | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | 1 | |
| sunflower oil | INACTIVE INGREDIENT | 3W1JG795YI | 1 | |
| tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| white wax | INACTIVE INGREDIENT | 7G1J5DA97F | 1 |
Products#
Every source-derived product name is available through these pages.
- Stressa Back and Neck Pain Relieving
- Menthol
- white wax
- CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)
- CETOSTEARYL ALCOHOL
- coconut oil
- dimethicone
- lemon oil
- Nutmeg oil
- Peppermint oil
- PINE NEEDLE OIL (PINUS SYLVESTRIS)
- Rosemary oil
- Sage oil
- PICEA MARIANA LEAF OIL
- CANANGA OIL
- Basil oil
- ARABICA COFFEE OIL
- Galbanum oil
- Hyssop oil
- METHYL SALICYLATE
- POLYOXYL 20 CETOSTEARYL ETHER
- glycerin
- glyceryl monostearate
- palm oil
- phenoxyethanol
- shea butter
- sunflower oil
- sodium citrate
- tocopherol
- water
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53882-001 | 53882-001-01, 53882-001-02, 53882-001-03, 53882-001-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, DELAYED RELEASE / ORAL | 15 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| Peppermint oil | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | EMULSION / ORAL | NA | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| METHYL SALICYLATE | METHYL SALICYLATE | LAV5U5022Y | CAPSULE / ORAL | 16 mg | ||
| POLYOXYL 20 CETOSTEARYL ETHER | POLYOXYL 20 CETOSTEARYL ETHER | YRC528SWUY | LOTION / TOPICAL | 71 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | CAPSULE / ORAL | 79 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Peppermint oil | PEPPERMINT OIL | AV092KU4JH | CAPSULE / ORAL | 60 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Peppermint oil | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / BUCCAL | 526 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| tocopherol | TOCOPHEROL | R0ZB2556P8 | CREAM / TOPICAL | NA | ||
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) | 4Q93RCW27E | CREAM / TOPICAL | 103 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | CREAM / VAGINAL | 40 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| POLYOXYL 20 CETOSTEARYL ETHER | POLYOXYL 20 CETOSTEARYL ETHER | YRC528SWUY | CREAM / TOPICAL | 180 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | TABLET, DELAYED RELEASE / ORAL | 0.08 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Nutmeg oil | NUTMEG OIL | Z1CLM48948 | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | SUPPOSITORY / RECTAL | 265 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, DELAYED RELEASE / ORAL | 6 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| Peppermint oil | PEPPERMINT OIL | AV092KU4JH | SOLUTION / DENTAL | 0.04 %v/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| METHYL SALICYLATE | METHYL SALICYLATE | LAV5U5022Y | POWDER / TOPICAL | NA | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE / ORAL | 13.75 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg | ||
| glyceryl monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / ORAL | 33.34 mg | ||
| white wax | WHITE WAX | 7G1J5DA97F | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6e022f69-388e-49e9-867e-78a7e57c8ede | 96372b6d-8346-480a-b292-958dd874b158 | 2012-12-05 | Warnings | 6e022f69-388e-49e9-867e-78a7e57c8ede 96372b6d-8346-480a-b292-958dd874b158 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.